Hong Kong Stocks Fall on Uncertainty in Further Stimulus; Pharma Firms Lead Decline

MT Newswires Live10-14

Hong Kong stocks fell on Monday following a holiday as investor sentiment waned after China's finance ministry failed to specify further stimulus measures for the economy.

The Hang Seng Index fell 0.75%, or 159.11 points, at 21,092.87. The Hang Seng China Enterprises index lost 0.54%, or 40.80 points, at 7,579.94.

Finance minister Lan Foan hinted at significantly increasing debt at a press conference held over the weekend but failed to provide any details on the size of the stimulus, leaving investors speculating.

Investor sentiment also took a hit as data from the statistics bureau on Sunday showed consumer inflation decelerating to 0.4% in September from 0.6% in August and producer prices plunging 2.8% for the 24th straight month, according to an SCMP report.

Pharma companies BeiGene (HKG:6160, SHA:688235), Innovent Biologics (HKG:1801), and CSPC Pharmaceutical (HKG:1093) led the decline with each of the companies' shares falling 5% at the close.

Sporting goods manufacturer Anta Sports Products (HKG:2020) also plunged 9%, with EV maker BYD (HKG:1211, SHE:002594) dropping 4% at Monday's close.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment